CSMS 50412777PGAACE OPSprocedural

FDA to Automate Electronic Messaging for Rescind Activities on 01/15/2022

Published Dec 16, 2021

Summary

FDA will automate electronic ACE messaging (new reason and subreason codes) for rescind activities on admissibility decisions, with testing on December 17, 2021 and production deployment on January 15, 2022.

Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.

CSMS 50412777 · full bulletin